UNITED THERAPEUTICS Corp·4

Mar 11, 4:30 PM ET

ROTHBLATT MARTINE A 4

4 · UNITED THERAPEUTICS Corp · Filed Mar 11, 2026

Research Summary

AI-generated summary of this filing

Updated

United Therapeutics CEO Martine Rothblatt Exercises Options, Sells 9,500

What Happened

  • Martine A. Rothblatt, Chairperson & CEO of United Therapeutics (UTHR), exercised 9,500 stock options on 2026-03-10 at a strike price of $146.03 (cost $1,387,285) and sold the resulting 9,500 shares the same day in multiple open‑market trades for total gross proceeds of $5,127,273. The sale was executed pursuant to a pre‑arranged 10b5‑1 trading plan.

Key Details

  • Transaction date: 2026-03-10 (Form 4 filed 2026-03-11; timely filing).
  • Options exercised: 9,500 @ $146.03 = $1,387,285 (reported as an acquisition).
  • Shares sold: 9,500 across many trades; total proceeds $5,127,273 (weighted average sale price ≈ $539.71).
  • Reported sale price range across trades: roughly $529.38 to $547.50 (see footnotes for per-trade ranges and weighted averages).
  • The filing shows the derivative position converted/removed consistent with the exercise (a derivative disposal line at $0).
  • Ownership after transaction: not specified in the provided excerpt; the filing includes disclosures of family trust holdings (footnotes F16–F19) — see the full Form 4 for total beneficial ownership.
  • Notable footnote: F1 — transactions were made under a 10b5‑1 plan adopted Nov 7, 2025, which continues until the earlier of exercise of 1,734,410 options (expire Mar 17, 2027) or Dec 31, 2026.

Context

  • This was an option exercise immediately followed by sales (a common "exercise-and-sell" or cashless-type pattern). The presence of a 10b5‑1 plan indicates the trades were pre‑arranged, which is routine for many insiders and generally intended to avoid concerns about trading on nonpublic information.

Insider Transaction Report

Form 4
Period: 2026-03-10
ROTHBLATT MARTINE A
DirectorChairperson & CEO
Transactions
  • Exercise/Conversion

    Common Stock

    [F1]
    2026-03-10$146.03/sh+9,500$1,387,2859,630 total
  • Sale

    Common Stock

    [F1][F2]
    2026-03-10$530.03/sh800$424,0248,830 total
  • Sale

    Common Stock

    [F1][F3]
    2026-03-10$530.49/sh120$63,6588,710 total
  • Sale

    Common Stock

    [F1]
    2026-03-10$531.54/sh40$21,2628,670 total
  • Sale

    Common Stock

    [F1]
    2026-03-10$533.23/sh40$21,3298,630 total
  • Sale

    Common Stock

    [F1][F4]
    2026-03-10$535.09/sh1,320$706,3217,310 total
  • Sale

    Common Stock

    [F1][F5]
    2026-03-10$535.99/sh459$246,0196,851 total
  • Sale

    Common Stock

    [F1][F6]
    2026-03-10$537.92/sh647$348,0366,204 total
  • Sale

    Common Stock

    [F1][F7]
    2026-03-10$539.02/sh563$303,4705,641 total
  • Sale

    Common Stock

    [F1][F8]
    2026-03-10$539.84/sh1,351$729,3224,290 total
  • Sale

    Common Stock

    [F1][F9]
    2026-03-10$540.63/sh440$237,8773,850 total
  • Sale

    Common Stock

    [F1][F10]
    2026-03-10$541.69/sh400$216,6763,450 total
  • Sale

    Common Stock

    [F1][F11]
    2026-03-10$542.88/sh560$304,0132,890 total
  • Sale

    Common Stock

    [F1][F12]
    2026-03-10$544.04/sh824$448,2902,066 total
  • Sale

    Common Stock

    [F1][F13]
    2026-03-10$545.05/sh936$510,1691,130 total
  • Sale

    Common Stock

    [F1][F14]
    2026-03-10$546.21/sh480$262,180650 total
  • Sale

    Common Stock

    [F1][F15]
    2026-03-10$547.14/sh400$218,855250 total
  • Sale

    Common Stock

    [F1]
    2026-03-10$548.10/sh120$65,772130 total
  • Exercise/Conversion

    Stock Option

    [F1]
    2026-03-109,500173,500 total
    Exercise: $146.03From: 2020-03-15Exp: 2027-03-15Common Stock (9,500 underlying)
Holdings
  • Common Stock

    (indirect: By Spouse)
    166
  • Common Stock

    [F16]
    (indirect: By Trust)
    324,518
  • Common Stock

    [F17]
    (indirect: By Trust)
    258,117
  • Common Stock

    [F18]
    (indirect: By Trust)
    45,596
  • Common Stock

    [F19]
    (indirect: By Trust)
    10,962
Footnotes (19)
  • [F1]This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 17, 2027; or (b) December 31, 2026.
  • [F10]This transaction was executed in multiple trades at prices ranging from $541.43 to $542.09. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F11]This transaction was executed in multiple trades at prices ranging from $542.54 to $543.48. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F12]This transaction was executed in multiple trades at prices ranging from $543.59 to $544.57. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F13]This transaction was executed in multiple trades at prices ranging from $544.705 to $545.68. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F14]This transaction was executed in multiple trades at prices ranging from $545.72 to $546.68. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F15]This transaction was executed in multiple trades at prices ranging from $546.835 to $547.50. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F16]Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
  • [F17]Shares held in family trusts as to which the Reporting Person's spouse is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
  • [F18]Shares held in family trusts as to which the Reporting Person's spouse shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
  • [F19]Shares held in family trusts as to which the Reporting Person is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
  • [F2]This transaction was executed in multiple trades at prices ranging from $529.38 to $530.35. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F3]This transaction was executed in multiple trades at prices ranging from $530.44 to $530.51. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F4]This transaction was executed in multiple trades at prices ranging from $534.69 to $535.66. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F5]This transaction was executed in multiple trades at prices ranging from $535.72 to $536.21. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F6]This transaction was executed in multiple trades at prices ranging from $537.24 to $538.22. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F7]This transaction was executed in multiple trades at prices ranging from $538.30 to $539.29. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F8]This transaction was executed in multiple trades at prices ranging from $539.30 to $540.21. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F9]This transaction was executed in multiple trades at prices ranging from $540.34 to $541.22. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Signature
/s/ John S. Hess, Jr. under Power of Attorney|2026-03-11

Documents

1 file
  • 4
    primarydocument.xmlPrimary

    PRIMARY DOCUMENT